恒瑞医药：公司稳步推进国际化战略，在欧盟地区有药品出口销售业务

Group 1 - The company is steadily advancing its internationalization strategy, particularly in the European Union region [1] - The company has a diverse approach to its drug export sales business in the EU [1] - Currently, the revenue from the EU business accounts for a small proportion of the company's overall operating income [1]